Emerging strategies for drug development in motor neuron disease

Expert Opinion on Investigational Drugs
Eric J Sorenson

Abstract

Until recently, attempts to identify disease-modifying treatments in motor neuron disease have largely failed. This was due to a lack of understanding of the disease pathogenesis and poor clinical trial design. Recent advances in the genetics of motor neuron disease and the maturation of tissue culture techniques have increased our understanding of the mechanisms of cell death in motor neuron disease. This has in turn led to better in vitro and transgenic animal models, allowing for a more systematic study of the disease process and analysis of potential therapeutic agents. With the advent of these models, motor neuron disease drug research has entered a new era. It is now possible to pursue mass screening of compounds in the in vitro models. Successful compounds in vitro can be advanced to the transgenic animal models. Once toxicity and potential therapeutic effects in animals are known, agents which remain promising can be taken to Phase I, II and III clinical trials. This will increase the likelihood of success and is more desirable than methods previously utilised. A hierarchical approach such as this will be even more important as multi-drug regimens are to be studied. The number of combinations for these multi-drug regime...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
May 1, 1980·Neurology·S M JuergensD W Mulder
Oct 1, 1995·Annals of Neurology·P J ShawD Mantle
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·J D RothsteinR W Kuncl
Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J D RothsteinR W Kuncl
Dec 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·A Radunovíc, P N Leigh
Jul 24, 1998·Hormone Research·H J Aanstoot
Feb 16, 1999·Brain Pathology·M R Cookson, P J Shaw
Sep 2, 1999·Nature Medicine·A MigheliC Bendotti
Oct 21, 1999·Neurobiology of Disease·J W RussellE L Feldman
Dec 14, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D LiuL Li
Nov 18, 2000·Annals of the New York Academy of Sciences·D A FiglewiczJ C Turcotte
Mar 14, 2001·Neurology·C F Ansevin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Shubham Misra, Bikash Medhi
The Journal of Nutrition, Health & Aging
P S Aisen
Lancet Neurology
Francesca MangialascheMiia Kivipelto
© 2022 Meta ULC. All rights reserved